Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier P Gisbert

Showing results (171-180 of 668) with videos related to

Pageof 67
Sort By:
Inflammatory Bowel Diseases|January 30, 2023
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic ReviewJavier P Gisbert, Elizabeth Parody-Rúa, María Chaparro
International Journal of Molecular Sciences|June 28, 2023
Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease DiagnosisMontse Baldan-Martin, María Chaparro, Javier P Gisbert
Helicobacter|November 13, 2024
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First-Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta-AnalysisBelén Martínez Benito, Olga P Nyssen, Javier P Gisbert
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 17, 2023
New drugs for the treatment of IBD during conception, pregnancy, and lactationDaniela Pugliese, Giuseppe Privitera, Javier P Gisbert, et al.
Helicobacter|February 16, 2019
Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pyloriOlga P Nyssen, Adrian G McNicholl, Javier P Gisbert
Medicina Clinica|September 15, 2005
[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]Javier P Gisbert, Xavier Calvet, Fernando Gomollón, et al.
Current Drug Metabolism|April 19, 2011
Utility of measuring serum concentrations of anti-TNF agents and anti-drug antibodies in inflammatory bowel diseaseIván Guerra, María Chaparro, Fernando Bermejo, et al.
Helicobacter|November 9, 2010
Treatment of Helicobacter pylori infection 2010Anthony O'Connor, Javier P Gisbert, Deirdre McNamara, et al.
Gut|March 6, 2023
Empiric use of standard triple therapy in <i>Helicobacter pylori</i> eradication does not require readjustment in the clarithromycin resistance cut-off pointPeter Malfertheiner, Francis Megraud, Theodore Rokkas, et al.
Helicobacter|September 11, 2012
Treatment of Helicobacter pylori infection 2012Bojan Tepes, Anthony O'Connor, Javier P Gisbert, et al.
Pageof 67

Showing results (171-180 of 668) with videos related to

Sort By:
Pageof 67
Inflammatory Bowel Diseases|January 30, 2023
Efficacy, Effectiveness, and Safety of Ustekinumab for the Treatment of Ulcerative Colitis: A Systematic ReviewJavier P Gisbert, Elizabeth Parody-Rúa, María Chaparro
International Journal of Molecular Sciences|June 28, 2023
Systematic Review: Urine Biomarker Discovery for Inflammatory Bowel Disease DiagnosisMontse Baldan-Martin, María Chaparro, Javier P Gisbert
Helicobacter|November 13, 2024
Efficacy and Safety of Vonoprazan in Dual/Triple/Quadruple Regimens Both in First-Line and Rescue Therapy for Helicobacter pylori Eradication: A Systematic Review With Meta-AnalysisBelén Martínez Benito, Olga P Nyssen, Javier P Gisbert
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 17, 2023
New drugs for the treatment of IBD during conception, pregnancy, and lactationDaniela Pugliese, Giuseppe Privitera, Javier P Gisbert, et al.
Helicobacter|February 16, 2019
Meta-analysis of three-in-one single capsule bismuth-containing quadruple therapy for the eradication of Helicobacter pyloriOlga P Nyssen, Adrian G McNicholl, Javier P Gisbert
Medicina Clinica|September 15, 2005
[Eradication treatment of Helicobacter pylori. Recommendations of the II Spanish Consensus Conference]Javier P Gisbert, Xavier Calvet, Fernando Gomollón, et al.
Current Drug Metabolism|April 19, 2011
Utility of measuring serum concentrations of anti-TNF agents and anti-drug antibodies in inflammatory bowel diseaseIván Guerra, María Chaparro, Fernando Bermejo, et al.
Helicobacter|November 9, 2010
Treatment of Helicobacter pylori infection 2010Anthony O'Connor, Javier P Gisbert, Deirdre McNamara, et al.
Gut|March 6, 2023
Empiric use of standard triple therapy in <i>Helicobacter pylori</i> eradication does not require readjustment in the clarithromycin resistance cut-off pointPeter Malfertheiner, Francis Megraud, Theodore Rokkas, et al.
Helicobacter|September 11, 2012
Treatment of Helicobacter pylori infection 2012Bojan Tepes, Anthony O'Connor, Javier P Gisbert, et al.
Pageof 67